2011 | Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein | 김화정; 이경림; 권영주; 맹지혜 | Article |
2011 | Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase i inhibitors with molecular modeling | 권영주 | Article |
2015 | Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents | 권영주; 전규연 | Article |
2015 | Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity | 권영주 | Article |
2007 | Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors | 이상국; 권영주 | Article |
2017 | Design, synthesis and biological evaluation of 1,3-diphenylbenzo[f] [1,7]naphthyrdines | 권영주; 전규연 | Article |
2011 | Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase i inhibitors | 권영주 | Article |
2014 | Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors | 권영주 | Article |
2012 | Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety | 권영주 | Article |
2018 | Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors | 권영주 | Article |
2023 | Design, synthesis, and biological evaluation of novel HSP27 inhibitors to sensitize lung cancer cells to clinically available anticancer agents | 권영주; 이윤실; 황수연; 전슬기 | Article |
2022 | Design, Synthesis, and Cytotoxicity and Topoisomerase I/IIα Inhibition Activity of Pyrazolo[4,3-f]quinoline Derivatives | 권영주 | Article |
2018 | Design, synthesis, and structure-activity relationships of new benzofuro [3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors | 권영주 | Article |
2018 | Design, synthesis, biological evaluation, structure-activity relationship study, and mode of action of 2-phenol-4,6-dichlorophenyl-pyridines | 권영주 | Article |
2016 | Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase II alpha catalytic inhibitor | 권영주; 전규연 | Article |
2007 | Develoment of novel calpain inhibitors functioning neuro-protection activity in neuronal apoptosis | 권영주 | Meeting Abstract |
2018 | Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II alpha inhibitors | 권영주 | Article |
2020 | Development of a database of capsaicinoid contents in foods commonly consumed in Korea | 권영주 | Article |
2014 | Development of an Albumin Copper Binding (ACuB) Assay to Detect Ischemia Modified Albumin | 전길자; 권영주 | Article |
2013 | Development of Neuroprotective Agents and Analytical Methods for Antioxidant’s Reactivity and Albumin’s Structural Modifications | 이은영 | Doctoral Thesis |
2014 | Development of Topoisomerase IIα Catalytic Inhibitors and Analysis of Their Anticancer Activity in Colon Cancer Cells | 박소은 | Master's Thesis |
2023 | Di-indenopyridines as topoisomerase II-selective anticancer agents: Design, synthesis, and structure–activity relationships | 권영주; 황수연; 박서정 | Article |
2016 | Dihydropyrazol Ethanone Derivative Attenuates HER2-mediated Cell Proliferation and Survival Signals in HER2-overexpressing Gastric Cancer Cells | 송찬주 | Master's Thesis |
2012 | Dihydroxylated 2,4,6-triphenyl pyridines: Synthesis, topoisomerase i and II inhibitory activity, cytotoxicity, and structure-activity relationship study | 권영주 | Article |
2017 | Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity | 권영주 | Article |
2019 | Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-b]pyridinol Derivatives as Potent Topoisomerase II alpha-Targeted Chemotherapeutic Agents for Breast Cancer | 권영주 | Article |
2022 | Discovery of (E)-3-(3-((2-Cyano-4' -dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis | 이화정; 김대기; 권영주; 최선; 박서정 | Article |
2021 | Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison | 권영주; 전경화; 황수연 | Article |
2018 | Discovery of an inhibitor of ESX-MED23 interaction as a novel strategy to overcome trastuzumab resistance in HER2 overexpressing human gastric cancer | 이화종 | Master's Thesis |
2014 | Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor | 권영주 | Article |